Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
出版年份 2020 全文链接
标题
Hepatocellular Carcinoma—The Influence of Immunoanatomy and the Role of Immunotherapy
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 18, Pages 6757
出版商
MDPI AG
发表日期
2020-09-15
DOI
10.3390/ijms21186757
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Efficacy and tolerance of immune checkpoint inhibitors in transplant patients with cancer: A systematic review
- (2020) Thibaut d’Izarny‐Gargas et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice
- (2020) Dan Li et al. GASTROENTEROLOGY
- Advancing CAR T-Cell Therapy for Solid Tumors: Lessons Learned from Lymphoma Treatment
- (2020) Aleksei Titov et al. Cancers
- Ipilumumab for hepatocellular cancer in a liver transplant recipient, with durable response, tolerance and without allograft rejection
- (2020) Abhishek Pandey et al. Immunotherapy
- Research progress and clinical prospect of immunocytotherapy for the treatment of hepatocellular carcinoma
- (2020) Yue Shi et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Programming CAR T cells to enhance anti-tumor efficacy through remodeling of the immune system
- (2020) Xiaohui Wang et al. Frontiers of Medicine
- Goals and targets for personalized therapy for HCC
- (2019) Thomas Couri et al. Hepatology International
- Role of the tumor microenvironment in PD-L1/PD-1-mediated tumor immune escape
- (2019) Xianjie Jiang et al. Molecular Cancer
- Breakdown of adaptive immunotolerance induces hepatocellular carcinoma in HBsAg-tg mice
- (2019) Lu Zong et al. Nature Communications
- The lineage stability and suppressive program of regulatory T cells require protein O-GlcNAcylation
- (2019) Bing Liu et al. Nature Communications
- Targeting immune cells for cancer therapy
- (2019) Sin Yee Gun et al. Redox Biology
- Novel immunotherapeutic approaches for hepatocellular carcinoma treatment
- (2019) Davide Busato et al. Expert Review of Clinical Pharmacology
- PD-1 inhibitors monotherapy in hepatocellular carcinoma: Meta-analysis and systematic review
- (2019) Ioannis A. Voutsadakis Hepatobiliary & Pancreatic Diseases International
- Next generation chimeric antigen receptor T cells: safety strategies to overcome toxicity
- (2019) Shengnan Yu et al. Molecular Cancer
- Current perspectives on the immunosuppressive tumor microenvironment in hepatocellular carcinoma: challenges and opportunities
- (2019) Chen Lu et al. Molecular Cancer
- Tumor-Infiltrating Leukocyte Composition and Prognostic Power in Hepatitis B- and Hepatitis C-Related Hepatocellular Carcinomas
- (2019) Yi-Wen Hsiao et al. Genes
- HBV-Induced Immune Imbalance in the Development of HCC
- (2019) Yongyan Chen et al. Frontiers in Immunology
- Emerging agents and regimens for hepatocellular carcinoma
- (2019) Xiao-Dong Zhu et al. Journal of Hematology & Oncology
- The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
- (2019) Peter G. Hendrickson et al. OncoImmunology
- Targeted agents for second-line treatment of advanced hepatocellular carcinoma
- (2019) Nicola Personeni et al. World Journal of Gastrointestinal Oncology
- Immune Responses in the Liver
- (2018) Paul Kubes et al. Annual Review of Immunology
- Annual Report to the Nation on the Status of Cancer, part I: National cancer statistics
- (2018) Kathleen A. Cronin et al. CANCER
- Hepatocellular carcinoma in the era of immunotherapy
- (2018) Hao-Wen Sim et al. CURRENT PROBLEMS IN CANCER
- Recent developments with immunotherapy for hepatocellular carcinoma
- (2018) Oliver Waidmann EXPERT OPINION ON BIOLOGICAL THERAPY
- Multidimensional analyses reveal distinct immune microenvironment in hepatitis B virus-related hepatocellular carcinoma
- (2018) Chun Jye Lim et al. GUT
- Chimeric antigen receptor-engineered T-cell therapy for liver cancer
- (2018) Yang Chen et al. Hepatobiliary & Pancreatic Diseases International
- EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
- (2018) Peter R. Galle et al. JOURNAL OF HEPATOLOGY
- Cabozantinib in Patients with Advanced and Progressing Hepatocellular Carcinoma
- (2018) Ghassan K. Abou-Alfa et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liver Resection and Surgical Strategies for Management of Primary Liver Cancer
- (2018) Sonia T. Orcutt et al. Cancer Control
- Natural killer cells in liver diseases
- (2018) Meijuan Zheng et al. Frontiers of Medicine
- Anti-PD-1 and Anti-CTLA-4 Therapies in Cancer: Mechanisms of Action, Efficacy, and Limitations
- (2018) Judith A. Seidel et al. Frontiers in Oncology
- Overexpression of epithelial cell adhesion molecule as a predictor of poor outcome in patients with hepatocellular carcinoma
- (2018) Chih‑Jan Ko et al. Experimental and Therapeutic Medicine
- Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
- (2018) Kook Hwan Kim et al. Frontiers in Endocrinology
- Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
- (2018) Jean-Luc Raoul et al. CANCER TREATMENT REVIEWS
- Prognostic value of tumor-infiltrating lymphocytes in hepatocellular carcinoma
- (2018) Wei Ding et al. MEDICINE
- Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
- (2017) Masao Omata et al. Hepatology International
- Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis
- (2017) Gonzalo Sapisochin et al. JOURNAL OF HEPATOLOGY
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
- (2017) Theo Ruers et al. JNCI-Journal of the National Cancer Institute
- Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial
- (2017) Jordi Bruix et al. LANCET
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches
- (2017) Gonzalo Sapisochin et al. Nature Reviews Gastroenterology & Hepatology
- Mechanisms of hepatic stellate cell activation
- (2017) Takuma Tsuchida et al. Nature Reviews Gastroenterology & Hepatology
- FDA Approves Second CAR T-cell Therapy
- (2017) Cancer Discovery
- Chronic Alcohol Consumption Promotes Diethylnitrosamine-Induced Hepatocarcinogenesis via Immune Disturbances
- (2017) Guoxiu Yan et al. Scientific Reports
- Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
- (2017) Theo Ruers et al. JNCI-Journal of the National Cancer Institute
- Liver immunology and its role in inflammation and homeostasis
- (2016) Mark W Robinson et al. Cellular & Molecular Immunology
- Alpha-foetoprotein (AFP): A multi-purpose marker in hepatocellular carcinoma
- (2016) Chloé Sauzay et al. CLINICA CHIMICA ACTA
- Targeting Alpha-Fetoprotein (AFP)–MHC Complex with CAR T-Cell Therapy for Liver Cancer
- (2016) Hong Liu et al. CLINICAL CANCER RESEARCH
- Adjuvant immunotherapy with autologous cytokine-induced killer cells for hepatocellular carcinoma patients after curative resection, a systematic review and meta-analysis
- (2016) Haiqing Wang et al. DIGESTIVE AND LIVER DISEASE
- Epidemiology and natural history of non-alcoholic fatty liver disease
- (2016) Yousef Fazel et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Global Epidemiology of Hepatocellular Carcinoma
- (2015) Katherine A. McGlynn et al. Clinics in Liver Disease
- Adjuvant Immunotherapy With Autologous Cytokine-Induced Killer Cells for Hepatocellular Carcinoma
- (2015) Joon Hyeok Lee et al. GASTROENTEROLOGY
- The yin and yang of evasion and immune activation in HCC
- (2015) Oxana V. Makarova-Rusher et al. JOURNAL OF HEPATOLOGY
- Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma
- (2015) Longhao Sun et al. TUMOR BIOLOGY
- Hepatocellular Carcinoma: Consensus, Controversies and Future Directions: A Report from the Canadian Association for the Study of the Liver Hepatocellular Carcinoma Meeting
- (2015) Kelly Warren Burak et al. Canadian Journal of Gastroenterology and Hepatology
- From the Reticuloendothelial to Mononuclear Phagocyte System – The Unaccounted Years
- (2015) Simon Yona et al. Frontiers in Immunology
- Liver resection for HCC: Patient's selection and controversial scenarios
- (2014) François Cauchy et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Hepatocellular carcinoma epidemiology
- (2014) Cristina Bosetti et al. BEST PRACTICE & RESEARCH IN CLINICAL GASTROENTEROLOGY
- Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma
- (2014) H. Gao et al. CLINICAL CANCER RESEARCH
- Inactivation of Wnt signaling by a human antibody that recognizes the heparan sulfate chains of glypican-3 for liver cancer therapy
- (2014) Wei Gao et al. HEPATOLOGY
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice
- (2014) Liufu Deng et al. JOURNAL OF CLINICAL INVESTIGATION
- Intersection of population variation and autoimmunity genetics in human T cell activation
- (2014) C. J. Ye et al. SCIENCE
- Regional delivery of mesothelin-targeted CAR T cell therapy generates potent and long-lasting CD4-dependent tumor immunity
- (2014) P. S. Adusumilli et al. Science Translational Medicine
- Immune Control in Hepatocellular Carcinoma Development and Progression: Role of Stromal Cells
- (2014) Martin Sprinzl et al. SEMINARS IN LIVER DISEASE
- Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
- (2014) Amit G. Singal et al. PLOS MEDICINE
- EpCAM-Targeted Therapy for Human Hepatocellular Carcinoma
- (2013) Kousuke Ogawa et al. ANNALS OF SURGICAL ONCOLOGY
- The liver in sepsis
- (2013) Michael Bauer et al. Current Opinion in Critical Care
- Glypican-3: a marker and a therapeutic target in hepatocellular carcinoma
- (2013) Jorge Filmus et al. FEBS Journal
- A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C
- (2013) Bruno Sangro et al. JOURNAL OF HEPATOLOGY
- Transplant benefit for patients with hepatocellular carcinoma
- (2013) Alessandro Vitale WORLD JOURNAL OF GASTROENTEROLOGY
- The Basic Principles of Chimeric Antigen Receptor Design
- (2013) Michel Sadelain et al. Cancer Discovery
- Peptide vaccines for hepatocellular carcinoma
- (2013) Daisuke Nobuoka et al. Human Vaccines & Immunotherapeutics
- Radiofrequency Ablation of Liver Tumors
- (2013) Debra Gervais et al. SEMINARS IN INTERVENTIONAL RADIOLOGY
- Combined Blockade of Programmed Death-1 and Activation of CD137 Increase Responses of Human Liver T Cells Against HBV, But Not HCV
- (2012) Paola Fisicaro et al. GASTROENTEROLOGY
- Enhancement of tumor-associated antigen-specific T cell responses by radiofrequency ablation of hepatocellular carcinoma
- (2012) Eishiro Mizukoshi et al. HEPATOLOGY
- Absence of receptor interacting protein kinase 3 prevents ethanol-induced liver injury
- (2012) Sanjoy Roychowdhury et al. HEPATOLOGY
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Comparison of Milan and UCSF criteria for liver transplantation to treat hepatocellular carcinoma
- (2011) Tarkan Unek WORLD JOURNAL OF GASTROENTEROLOGY
- Radioembolization for Hepatocellular Carcinoma
- (2010) Bruno Sangro et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
- (2010) Jiwei Huang et al. ANNALS OF SURGERY
- Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis
- (2010) Herbert Tilg et al. HEPATOLOGY
- Tumor-infiltrating lymphocytes and hepatocellular carcinoma: pathology and clinical management
- (2010) Ken Shirabe et al. International Journal of Clinical Oncology
- The promise and potential pitfalls of chimeric antigen receptors
- (2009) Michel Sadelain et al. CURRENT OPINION IN IMMUNOLOGY
- Sorafenib
- (2009) Gillian M. Keating et al. DRUGS
- Antiviral Intrahepatic T-Cell Responses Can Be Restored by Blocking Programmed Death-1 Pathway in Chronic Hepatitis B
- (2009) Paola Fisicaro et al. GASTROENTEROLOGY
- Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome
- (2009) Avlin B. Imaeda et al. JOURNAL OF CLINICAL INVESTIGATION
- Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR–induced stop signal
- (2009) Brian T Fife et al. NATURE IMMUNOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Microanatomy of the liver immune system
- (2009) Eszter Nemeth et al. Seminars in Immunopathology
- Glypican 3 Expression in Human Nonneoplastic, Preneoplastic, and Neoplastic Tissues
- (2008) Daniel Baumhoer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Dynamic Programmed Death 1 Expression by Virus-Specific CD8 T Cells Correlates With the Outcome of Acute Hepatitis B
- (2008) Zheng Zhang et al. GASTROENTEROLOGY
- EpCAM-Positive Hepatocellular Carcinoma Cells Are Tumor-Initiating Cells With Stem/Progenitor Cell Features
- (2008) Taro Yamashita et al. GASTROENTEROLOGY
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
- Preclinical overview of sorafenib, a multikinase inhibitor that targets both Raf and VEGF and PDGF receptor tyrosine kinase signaling
- (2008) Scott M. Wilhelm et al. MOLECULAR CANCER THERAPEUTICS
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now